
Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …

Affinivax has received an award of $22 million funding from CARB-X, a global non-profit organisation, to develop a vaccine targeting Staphylococcus …

Immunotherapy platform developer Valo Therapeutics has successfully completed a collaboration with the biotechnology company ImmunoScape to identify immunogenic peptides for …

CureVac and Novartis have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV. Preparations for the …

The Centre for Process Innovation (CPI) has received a £5 million investment from the UK government, to support the development …

ConserV Bioscience and eTheRNA immunotherapies have agreed to collaborate on the development of vaccine candidates for infectious diseases. ConserV is …

The FDA has issued emergency use authorisation for Johnson & Johnson’s one-shot COVID-19 vaccine, approving the jab for use in …

World health officials have moved to ease concerns over the efficacy of the Oxford University-AstraZeneca vaccine against new variants of …

Johnson & Johnson has announced that its COVID-19 vaccine candidate is 85% effective in preventing serious symptoms of the disease, …

A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …

Kate Bingham, the head of the British Government’s vaccine taskforce, faces scrutiny after it was revealed her venture capital firm …

Public Health England has warned that catching seasonal flu and coronavirus at the same time could almost double the risk …

Clinical trials testing Russia’s Sputnik-V coronavirus vaccine in India could begin in the next few weeks, according to Indian pharma …

The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the …

The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …